Mazda recalling 190,000 CX-7 vehicles in U.S.
- Healthcare, tech stocks drive Wall Street higher
- Twitter (TWTR) Tops Q3 EPS by 4c; Announces Restructuring, Workforce Reduction
- Qualcomm (QCOM) to Acquire NXP Semi (NXPI) in $47B Deal
- Tesla (TSLA) Posts Q3 adj.-EPS of 71c
- Pre-Open Stock Movers 10/27: (PRQR) (OCN) (TWTR) Higher; (CYH) (GNC) (RNWK) Lower (more...)
The 2010 Mazda CX-7 is unveiled at the 2009 New York International Auto Show April 9, 2009. REUTERS/Eric Thayer
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
DETROIT (Reuters) - Mazda Motor Corp <7261.T> will recall 190,000 of its CX-7 sport utility vehicles from model years 2007 to 2012 in the United States because of an issue that may cause a loss of steering control, U.S. safety regulators said on Friday.
"In the affected vehicles, water may enter the front suspension ball joint fittings," the National Highway Traffic Safety Administration said in a statement on its website.
"If the water is contaminated with salt, such as from driving on snowy roads that have been treated, the ball joint may corrode and separate from the lower control arm, resulting in a loss of steering control."
Mazda told regulators it will work to fix CX-7s in cold-weather U.S. states first.
In July 2015, Mazda recalled about 193,000 of its larger CX-9 SUVs from model years 2007 to 2014, for a similar issue.
Mazda said it has gotten no reports of injuries or crashes in the CX-7 SUVs.
Mazda did not immediately respond to an inquiry on whether any vehicles outside of the U.S. market will be recalled.
(Reporting by Bernie Woodall; Editing by Frances Kerry)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Man shot dead outside U.S. embassy in Kenya: media
- Russia's Putin says attempts to get Syria deal with Obama thwarted
- U.S. business spending tepid; labor market firming
Create E-mail Alert Related CategoriesReuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!